Integrated triplex LFIA platform for decentralized molecular subtyping of breast cancer
Abstract
> 0.95) across subtype-representative biomarker mixtures. Together, this integrated approach has the potential to enhance breast cancer diagnosis and management by addressing critical barriers to timely and accurate subtyping, providing a practical tool to support earlier intervention, expand access to personalized treatment, and improve patient outcomes in resource-limited settings.
Fields of Study & Subjects
Advanced Biosensing Techniques and Applications
Advanced Fluorescence Microscopy Techniques
Advanced biosensing and bioanalysis techniques
Publication details
- Journal / source
- RSC Advances
- Publisher
- Royal Society of Chemistry (RSC)
- Volume
- 16
- Issue
- 26
- Pages
- 23884–23894
- Publication date
- 1 January 2026
- Language
- EN